Title: The cost-effectiveness of celecoxib and rofecoxib in patients with osteoarthritis or rheumatoid arthritis
Subjects: Cost effectiveness, Therapeutic use, Osteoarthritis, Drug therapy, Chemotherapy, Cost-Benefit Analysis, Rheumatoid arthritis, Nonsteroidal anti-inflammatory agents, Cyclooxygenase 2, Rofecoxib, Cyclooxygenase Inhibitors, Arthritis, Rheumatoid, Inhibitors, Celecoxib